Biological medicine for treating cardio-cerebral vascular diseases and preparation method thereof
A technology for cardiovascular and cerebrovascular diseases and biological drugs, which is applied in cardiovascular system diseases, blood diseases, metabolic diseases and other directions to achieve the effects of improving cardiac function, simple preparation process and removing lipid deposition
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0012] A biological drug for treating cardiovascular and cerebrovascular diseases described in Example 1 of the present invention, the monarch drug contains 800 parts by weight of badger oil, and the minister drug contains 5 parts by weight of ginseng, 10 parts by weight of ganoderma lucidum powder and 14 parts by weight of kudzu root powder; The adjuvant medicine includes 30 parts by weight of lotus leaf, 30 parts by weight of apocynum leaf, 17 parts by weight of seaweed, 28 parts by weight of scutellaria baicalensis, 16 parts by weight of Atractylodes rhizome and 28 parts by weight of Fuling;
[0013] The preparation method of a biological drug for the treatment of cardiovascular and cerebrovascular diseases comprises the following steps: taking the adjuvant and adding water to heat and extract three times, adding water 8 times the total weight of Chinese medicinal materials for the first time and heating to 80 degrees Celsius, constant temperature Extract for 2 hours, separa...
Embodiment 2
[0015] A biological drug for the treatment of cardiovascular and cerebrovascular diseases described in Example 2 of the present invention, the principal drug contains 800 parts by weight of badger oil, the subject drug contains 7 parts by weight of ginseng, 14 parts by weight of ganoderma lucidum powder and 16 parts by weight of kudzu root powder Parts by weight; the adjuvant includes 32 parts by weight of lotus leaf, 32 parts by weight of Apocynum baicalensis, 19 parts by weight of seaweed, 32 parts by weight of Scutellaria baicalensis, 18 parts by weight of Atractylodes Rhizoma Rhizome, 32 parts by weight of Fuling; 12 parts by weight. The preparation method is the same as in Example 1.
Embodiment 3
[0017] A biological medicine for treating cardiovascular and cerebrovascular diseases described in Example 3 of the present invention, the monarch drug contains 800 parts by weight of badger oil, and the minister drug contains 6 parts by weight of ginseng, 12 parts by weight of ganoderma lucidum powder and 15 parts by weight of pueraria root powder; The adjuvant medicine includes 31 parts by weight of lotus leaf, 31 parts by weight of apocynum leaf, 18 parts by weight of seaweed, 30 parts by weight of scutellaria baicalensis, 17 parts by weight of Atractylodes macrocephala, and 30 parts by weight of Fuling; the main medicine contains 11 parts by weight of hawthorn. The preparation method is the same as in Example 1.
[0018] The badger oil described in the embodiments of the present invention is the most valuable badger oil, and the present invention takes the purified badger oil as an example, but is not limited to the badger oil.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

